Tenderfy

Next Generation Sequencing Testing (NGS)

Acheteur
NHS Blood and Transplant
Publié
2026-10-26
Échéance
Non indiqué
Sources
UK_FTS
Valeur
Non indiqué

Description

La description est dans la langue de la source.

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Abonnement

Consultez gratuitement les aperçus. Les liens vers les avis officiels et leurs documents, les permis de construire et l’accès MCP personnel nécessitent un abonnement payant actif.

Lire